Published in
American Society for Pharmacology and Experimental Therapeutics (ASPET), The Journal of Pharmacology and Experimental Therapeutics, 2(371), p. 320-326, 2019
Links
Tools
CC-115, a dual mTOR/DNA-PK inhibitor in clinical trial, is a substrate of ABCG2, a risk factor for CC-115 resistance
Journal article published in 2019 by
Jenny Beebe,
Jian-Ting Zhang 
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 